Mission and Vision


To develop highly selective, well-tolerated, and highly effective anti-cancer agents, by selectively targeting altered metabolism in cancer cells. Our immediate goal is to improve the quality of life of patients with pancreatic cancer, which is the deadliest cancer worldwide and has limited treatment options.


We aspire to be a premier oncology company with a primary focus to extend and enhance the lives of patients with difficult to treat cancers.